$MCURF News
Last published 3y ago
- 3y agoMCURFMINDCURE Announces Financial Results for the Third Quarter of Fiscal 2023PR NewswireVANCOUVER, BC, April 20, 2023 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQB:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company") today announced its financial results for the three and nine months
- 3y agoMCURFMINDCURE Announces Financial Results for the Second Quarter of Fiscal 2023PR NewswireVANCOUVER, BC, Jan. 25, 2023 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQB:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company") today announced its financial results for the three and six months ended
- 4y agoMCURFMINDCURE Announces Financial Results for the First Quarter of Fiscal 2023PR NewswireVANCOUVER, BC, Oct. 26, 2022 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQB:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company") today announced its financial results for the three months ended August
- 4y agoMCURFMINDCURE Announces Financial Results for Fiscal 2022PR NewswireVANCOUVER, BC, Sept. 13, 2022 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQX:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company") today announced its financial results for the three and twelve months ended May 31, 2022. All amounts are stated in Ca
- 4y agoMCURFMINDCURE Announces Financial Results for the Third Quarter of Fiscal 2022PR NewswireVANCOUVER, BC, April 26, 2022 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQX:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company") today announced its financial results for the three and nine months ended February 28, 2022. All amounts are stated in
- 4y agoMCURFMINDCURE Provides Update on Strategic ReviewPR NewswireAnnounces Executive and Employee Reductions and Cost Saving Measures VANCOUVER, BC, March 16, 2022 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQX:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), announced today that a special committee of the
- 4y agoATAICYBNENVBFTRP+3Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory CouncilPR NewswireDETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the psychedelics space, composed of key thought leaders sharing insights into industry developments, sector trends and br
- 4y agoMCURFMINDCURE Achieves Key Development Milestone for Novel Ibogaine ProgramPR NewswireProvisional Patent Filed on Non-Racemic Ibogaine Mixtures VANCOUVER, BC, March 2, 2022 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQX:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology for mental heal
- 4y agoMCURFMINDCURE Announces Strategic ReviewPR NewswireIndependent Special Committee Formed VANCOUVER, BC, Feb. 10, 2022 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQX:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology for mental health care and research
- 4y agoMCURFMINDCURE Hires Dr. Clare Purvis from Headspace to the position of Chief Product Officer to Advance Mental Health Digital Therapeutics PlatformPR NewswireVANCOUVER, BC, Feb. 3, 2022 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQX:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology for mental health care and research in psychedelics, announced today the hirin
- 4y agoAWKNFMCURFMINDCURE Announces Financial Results for the Second Quarter of Fiscal 2022PR NewswireVANCOUVER, BC, Jan. 25, 2022 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQX:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research for psychedelics, today announced its financial results and oper
- 4y agoMCURFMINDCURE to Participate in the H.C. Wainwright Bioconnect Conference in January 2022PR NewswireVANCOUVER, BC, Jan. 6, 2022 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQX:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research for psychedelics, today announced that President & Chief Executiv
- 4y agoACOGFBABYFEMMAJNHMF+8Life Sciences Companies Investor Presentations Now Available for On-Demand ViewingPR NewswireNEW YORK, Dec. 20, 2021 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the December 16th Life Sciences Virtual Investor Conference are now available for on-de
- 4y agoCYBNMCURFNVMDFWhy Some Psychedelic Assisted Therapy Clinics Are Turning To Artificial Intelligence for Digital Mental TherapiesPR NewswirePALM BEACH, Fla., Dec. 16, 2021 /PRNewswire/ -- Drugs like ketamine and psilocybin — the active ingredient in magic mushrooms — are showing real promise in addressing mental health disorders. More and more psychedelic-assisted psychotherapy clinics,
- 4y agoMCURFMINDCURE Announces Certification of HIPAA Compliance, Bringing iSTRYM Closer to Commercial Deployment in the Second Quarter of 2022PR NewswireVANCOUVER, BC, Dec. 16, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQX:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research for psychedelics, announced today that the Company and its digit
- 4y agoATAICMPSFTRPMCURF+1North American Psychedelic Drugs Market Expected To Reach A Value Of $3.184 Billion In 2026PR NewswirePALM BEACH, Fla., Dec. 14, 2021 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - The prevalence of mental health disorders has risen exponentially, and the development of novel medications has not kept pace, precipitating a crisis in psychiatri
- 4y agoMCURFMINDCURE Appoints Dr. Doron Sagman as Chief Medical OfficerPR NewswireVANCOUVER, BC, Dec. 14, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQX:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research for psychedelics, announces the appointment of Doron Sagman, MD,
- 4y agoACOGFBABYFEMMAHMTXF+7Life Sciences Virtual Investor Conference: Company Executives Present Live December 16thPR NewswireNEW YORK, Dec. 9, 2021 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, announced the agenda for its quarterly event for public and private companies, investors, and industry professionals from around the
- 4y agoMCURFMINDCURE to Participate in Upcoming Conferences in December 2021PR NewswireVANCOUVER, BC, Dec. 2, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQX:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research for psychedelics, today announced that President & Chief Executiv
- 5y agoATAICMPSCYBNMCURFIncreasing Prevalence of Depression & Mental Health Disorders Fueling Huge Growth in Psychedelic Drugs MarketPR NewswirePALM BEACH, Fla., Nov. 4, 2021 /PRNewswire/ -- The pace of society's change in attitude to the use of psychedelics has been amazing. It has gone from a "Born To Be Wild", hippie counter-culture illegal drug… to a rapidly growing mainline, positi
- 5y agoMCURFMINDCURE Provides Update on Studies and Clinical TrialsPR NewswireVANCOUVER, BC, Nov. 4, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQX:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research for psychedelics, is pleased to provide an operational progress
- 5y agoAWKNFCYBNFTRPMCURF+1Developments with Ketamine Psychotherapy Are Driving A Medical Revolution For Treating Mental Health IssuesPR NewswirePALM BEACH, Fla., Oct. 28, 2021 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - Psychedelic drugs such as psilocybin, LSD and MDMA have tremendous medical and commercial future potential… and for ketamine, the "future" is now. Drug developers
- 5y agoAWKNFMCURFMINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, MINDCURE's Digital Therapeutics PlatformPR NewswireVANCOUVER, BC, Oct. 28, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQX:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research for psychedelics, is pleased to announce the signing of a non-bi
- 5y agoMCURFMINDCURE Announces Participation at Upcoming Events in November 2021PR NewswireVANCOUVER, BC, Oct. 27, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQB:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research in psychedelics, today announced that Kelsey Ramsden, President
- 5y agoAWKNFBETRFBMBIFCYBN+16KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand ViewingPR NewswireNEW YORK, Oct. 18, 2021 /PRNewswire/ -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the presentations from the KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing.
- 5y agoAWKNFBETRFBMBIFCYBN+13KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14thPR NewswireNEW YORK, Oct. 11, 2021 /PRNewswire/ -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the agenda for the upcoming KCSA Psychedelics Virtual Investor Conference. Individual investors, institutional inves
- 5y agoMCURFMINDCURE to Webcast Live at the KCSA Psychedelics Virtual Investor Conference on October 13, 2021PR NewswireMINDCURE invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com VANCOUVER, BC, Oct. 7, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (O
- 5y agoMCURFOTCMMINDCURE Announces Commencement of Trading on the OTCQX Best MarketPR NewswireReinforces MINDCURE's financial integrity and provides greater visibility to U.S. Investors VANCOUVER, BC, Sept. 30, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQX:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced pr
- 5y agoMCURFOTCMOTC Markets Group Welcomes Mind Cure Health Inc. to OTCQXPR NewswireNEW YORK, Sept. 30, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX:OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced Mind Cure Health Inc. (CSE:MCUR, OTCQX:MCURF) a life sciences company focused on developin
- 5y agoMCURFMINDCURE to Present at the Benzinga Healthcare Small Cap ConferencePR NewswireVANCOUVER, BC, Sept. 28, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQB:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research in psychedelics, today announced that Kelsey Ramsden, Presid
- 5y agoMCURFMINDCURE Launches "Desire Project" To Treat Female Hypoactive Sexual Desire Disorder With MDMA-Assisted PsychotherapyPR NewswireFirst-of-its-kind study targets a female sexual disorder affecting an estimated 9.5 million women in the U.S. alone VANCOUVER, BC, Sept. 27, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQB:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"),
- 5y agoMCURFMINDCURE Signs Exclusive Digital Clinical Data Licensing Agreement with ATMA Journey CentersPR NewswireMINDCURE to utilize patient data provided by ATMA to optimize iSTRYM, its digital therapeutics platform VANCOUVER, BC, Sept. 23, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQB:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader
- 5y agoMCURFMINDCURE Announces Inclusion in AdvisorShares Psychedelics ETFPR NewswireVANCOUVER, BC, Sept. 22, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQB:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research in psychedelics, announced today it has been included in the
- 5y agoMCURFMINDCURE to Participate in Maxim Group LLC's Advances in Mental Health Virtual ConferencePR NewswireVANCOUVER, BC, Sept. 17 , 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQB:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research in psychedelics, today announced that Kelsey Ramsden, Presiden
- 5y agoMCURFMINDCURE Joins Digital Therapeutics Alliance to Drive Innovation in the Mental Health IndustryPR NewswireVANCOUVER, BC, Sept. 16, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQB:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research in psychedelics, announced today it's joining the Digital Thera
- 5y agoMCURFMINDCURE Announces Platinum Sponsorship of the 2021 SANA SymposiumPR NewswireAs the official meeting of the Psychedelic Medicine Association, this conference will connect mental health professionals with promising research and breakthrough treatment therapies from the emerging field. VANCOUVER, BC, Sept. 9, 2021 /PRNewswire/
- 5y agoMCURFMINDCURE to Present at the H.C. Wainwright 23rd Annual Global Investment ConferencePR NewswireVANCOUVER, BC, Sept. 8, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQB:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research in psychedelics, today announced that Kelsey Ramsden, President
- 5y agoMCURFMINDCURE Announces Financial Results for Fiscal 2021PR NewswireVANCOUVER, BC, Aug. 31, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQB:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research in psychedelics, today announced its financial results for the t
- 5y agoMCURFMINDCURE Reaches Milestone, Releasing First of its Kind Mental Health Digital Therapeutics Platform to Partner Clinics in North AmericaPR NewswireWith its minimum viable product (MVP) release on schedule and on budget, MINDCURE will work with its clinical partners to refine the application before full commercial deployment in Q1 2022. VANCOUVER, BC, Aug. 26, 2021 /PRNewswire/ - Mind Cure Healt
- 5y agoMCURFInvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Kelsey Ramsden, Co-Founder & CEO of Mind Cure Health Inc.GlobeNewswireNEW YORK, Aug. 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork ("IBN"), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the late
- 5y agoMCURFMINDCURE Welcomes Dr. Ken Weingardt, Digital Therapy Visionary, as a Senior Clinical Technology Advisor to its Psychedelic Digital Therapeutics TeamPR NewswireDr. Weingardt, a clinical psychologist and previously a Senior Clinical Director at Pear Therapeutics will guide MINDCURE's digital therapeutics technology (DTx) platform, iSTRYM, through near-term commercial deployment VANCOUVER, BC, Aug. 10, 2021 /
- 5y agoMCURFMINDCURE Appoints Jerry White, Award-Winning Humanitarian Activist Who Shares in the 1997 Nobel Peace Prize, as Company AdvisorPR NewswireThe recipient of numerous human rights and leadership awards, Mr. White will assist MINDCURE on its mission to revolutionize mental health treatments through the development and scaling of science-backed psychedelic medicines globally. VANCOUVER, BC,
- 5y agoMCURFMINDCURE Launches Second Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical ResearchPR NewswireMINDCURE's pharmaceutical grade ibogaine would provide researchers access to a sustainable, high-quality, reliable, and consistent supply of the psychedelic drug. VANCOUVER, BC, July 27, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQB:MCU
- 5y agoMCURFMINDCURE Announces Filing of U.S. Provisional Patent Applications for Company's First Fully Synthetic Routes to Create an Ibogaine Psychedelic CompoundPR NewswireThe company's pharmaceutical grade ibogaine would provide researchers access to a sustainable, high-quality, reliable, and consistent supply of the psychedelic drug, ibogaine. VANCOUVER, BC, July 13, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:M
- 5y agoMCURFMINDCURE Adopts Advance Notice PolicyPR NewswireVANCOUVER, BC, July 12, 2021 /CNW/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQB:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research for psychedelics, is pleased to announce that the Company's board o
- 5y agoMCURFMINDCURE Develops Proprietary Ketamine-Enhanced Psychotherapy Protocols for Treatment of Pain and DepressionPR NewswireMINDCURE will distribute these protocols to therapists through iSTRYM, its digital therapeutics platform. This milestone in protocol development unlocks the company's protocol distribution platform in time for iSTRYM's clinical MVP launch in Q3 2021.
- 5y agoMCURFMINDCURE Successfully Completes First Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical ResearchPR NewswireBy manufacturing ibogaine, MINDCURE's research team will have access to a predictable and standardized supply of synthetic ibogaine while ensuring consistent dosing and reliable results. VANCOUVER, BC, June 3, 2021 /PRNewswire/ - Mind Cure Health Inc
- 5y agoMCURFDr. Joel Raskin, a leader in psychiatry and neuroscience drug development, joins MINDCURE as Chief Medical OfficerPR NewswireDr. Raskin is a psychiatrist and academic with 20 years of international pharmaceutical experience in neuroscience drug development, lifecycle preparation, launch, and commercialization VANCOUVER, BC, May 20, 2021 /PRNewswire/ - Mind Cure Health Inc
- 5y agoMCURFMINDCURE Appoints Dr. John Brownstein, the Chief Innovation Officer at Boston Children's Hospital, as Company AdvisorPR NewswireDr. Brownstein, an esteemed epidemiologist, researcher at Boston Children's Hospital and professor at Harvard Medical School, will assist on MINDCURE's digital technology, data optimization and patient data security within iSTRYM, its psychedelic digital
- 5y agoMCURFMINDCURE Announces Partnership with SOMA Breath Inc. to License its Breathwork Program and Develop Custom Breathwork for Psychedelic-Assisted Psychotherapies within iSTRYMPR NewswireBreathwork has shown promise at both replicating the experience of psychedelics and helping patients to integrate psychedelic-assisted psychotherapy into their lives VANCOUVER, BC, April 27, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQB